A novel droplet digital polymerase chain reaction for diagnosis of pneumocystis pneumonia (PCP)-a clinical performance study and survey of sulfamethoxazole-trimethoprim resistant mutations.

[1]  Chong-Jen Yu,et al.  Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patients , 2019, Infection and drug resistance.

[2]  H. Germain,et al.  Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data , 2017, Scientific Reports.

[3]  C. Lehmann,et al.  Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort , 2017, Infection.

[4]  M. Chabé,et al.  High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy , 2016, Antimicrobial Agents and Chemotherapy.

[5]  L. Pagano,et al.  ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. , 2016, The Journal of antimicrobial chemotherapy.

[6]  K. Traore,et al.  Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[7]  M. Gari-Toussaint,et al.  Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients , 2016, Journal of Clinical Microbiology.

[8]  V. Thamlikitkul,et al.  Monitoring of Effectiveness and Safety of Colistin for Therapy in Resistant Gram-Negative Bacterial Infections in Hospitalized Patients at Siriraj Hospital. , 2016, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[9]  C. Hennequin,et al.  Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii , 2015, Journal of Clinical Microbiology.

[10]  É. Azoulay,et al.  Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France , 2014, Emerging infectious diseases.

[11]  W. Ko,et al.  Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. , 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[12]  Huiping Li,et al.  Evaluation of PCR in Bronchoalveolar Lavage Fluid for Diagnosis of Pneumocystis jirovecii Pneumonia: A Bivariate Meta-Analysis and Systematic Review , 2013, PloS one.

[13]  Christopher M. Hindson,et al.  Absolute quantification by droplet digital PCR versus analog real-time PCR , 2013, Nature Methods.

[14]  J. Brion,et al.  Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[15]  S. Ichiyama,et al.  Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  Ke Wang,et al.  PCR Diagnosis of Pneumocystis Pneumonia: a Bivariate Meta-Analysis , 2011, Journal of Clinical Microbiology.

[17]  F. Derouin,et al.  Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  A. Rauch,et al.  Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients , 2011, European Respiratory Journal.

[19]  M. Mungthin,et al.  Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients. , 2008, Medical mycology.

[20]  E. Vidal-Petiot,et al.  Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection , 2008, Critical care.

[21]  P. Goussard,et al.  Dihydropteroate Synthase and Novel Dihydrofolate Reductase Gene Mutations in Strains of Pneumocystis jirovecii from South Africa , 2005, Journal of Clinical Microbiology.

[22]  Jacques Bille,et al.  Mutations of Pneumocystis jirovecii Dihydrofolate Reductase Associated with Failure of Prophylaxis , 2004, Antimicrobial Agents and Chemotherapy.

[23]  Kristina Crothers,et al.  Dihydropteroate Synthase Gene Mutations in Pneumocystis and Sulfa Resistance , 2004, Emerging infectious diseases.

[24]  Michael L Wilson,et al.  Detection of Pneumocystis jiroveci in Respiratory Specimens by Four Staining Methods , 2004, Journal of Clinical Microbiology.

[25]  A. Limper,et al.  Medical progress: Pneumocystis pneumonia , 2004 .

[26]  Jacques Bille,et al.  Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. , 2003, The Journal of infectious diseases.

[27]  D. Turner,et al.  Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients: new data, new issues , 2003, European Respiratory Journal.

[28]  J. Kovacs,et al.  Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. , 2002, The Journal of infectious diseases.

[29]  S. Fischer,et al.  Development and Evaluation of a Quantitative, Touch-Down, Real-Time PCR Assay for Diagnosing Pneumocystis carinii Pneumonia , 2002, Journal of Clinical Microbiology.

[30]  C. Beard,et al.  Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. , 2000, The Journal of infectious diseases.

[31]  J. Kovacs,et al.  Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. , 1999, The Journal of infectious diseases.

[32]  J. Lundgren,et al.  Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia , 1999, The Lancet.

[33]  S. Fischer,et al.  Development of a PCR assay for diagnosis of Pneumocystis carinii pneumonia based on amplification of the multicopy major surface glycoprotein gene family. , 1999, Diagnostic microbiology and infectious disease.

[34]  A. Antinori,et al.  Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. , 1993, Journal of medical microbiology.

[35]  D. Church,et al.  Development and validation of a Pneumocystis jirovecii real-time polymerase chain reaction assay for diagnosis of Pneumocystis pneumonia , 2015, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.